MUMeral Unur

Meral Unur

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meral Unur has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Diagnostic Value of Minor Salivary Gland Biopsy: A Retrospective Study

    by Umutcan Demi̇ral, Gökay Karapinar, Hasan Ekmekci̇oğlu, Meral Ünür

    Objective: Minor salivary gland biopsy is an adjunctive diagnostic method which is widely used and its diagnostic value is still controversial. It is mainly used in sarcoidosis and Sjogren's Syndrome. This study aims to identify the contribution of histopathological diagnosis to clinical diagnosis and to supply information to literature. Methods: Minor salivary gland biopsy was carried out on the patients with early diagnosis of sarcoidosis or Sjogren's Syndrome who were referred from the hospital clinics of Istanbul University Faculty of Medicine, to the Oral and Maxillofacial Surgery Department of the Faculty of Dentistry. 100 patients between the ages of 18-65 were performed lower lip MSGB, then patients were called, the questions were asked and the answers were evaluated. Results: The presence of dry mouth was statistically higher in patients with Sjogren's Syndrome than histopathologically normal patient and sarcoidosis patients. In patients with Sjogren's syndrome, the presence of dry eyes was found to be statistically significantly higher than the others. A statistically significant difference of clinical diagnosis distribution was observed between the patients with normal histopathological findings and patients with mild inflammation infiltration, granulomatous sialadenitis and lymphocytic sialadenitis. Conclusion: Minor salivary gland biopsy is an easy and trusted method for establishing sarcoidosis and Sjogren's Syndrome diagnosis and follow-up. Studies reveal that as more knowledge about disease immunology is collected and more sensitive techniques for interpretation of saliva and other serological markers are developed, less invasive or noninvasive techniques will come into question. Contemporarily, it will continue to be one of the main diagnostic tests for adjunctive diagnostic of multisystemic chronic diseases.

  • Open Access

    Comparison of a new medicinal plant extract and triamcinolone acetonide in treatment of recurrent aphthous stomatitis

    by M. Unur, D. Ofluoglu, M. Koray, G. Mumcu, A.E. Onal, H. Tanyeri

    The aim of this study was to evaluate the effectiveness of a new medicinal plant extract (Ankaferd Blood Stopper®, ABS) on the healing process of aphthous ulcers. A total of 50 patients with recurrent aphthous stomatitis (RAS) who have had currently a single oral ulcer in the mouth were included in the study. Patients were randomly divided in 2 groups: ABS group and Kenacort group (triamcinolone acetonid). Data were collected by questionnaire regarding age, gender, RAS history including the number of ulcer episodes in 1 month, the number of ulcers in each episode, mean healing time of previous ulcers and the mean disease duration. Ulcer size, ulcer related pain, evaluated by VAS and effectiveness index (EI), was noted in each clinical examination. In the present study, no significant differences were seen in demographic and RAS related data between the 2 groups. In ABS and Kenacort group, the mean ulcer size and VAS scores were statistically reduced at day 3 and day 7 compared to baseline values, yet no significant difference was observed between the 2 groups in these time points. The effects of ABS in RAS treatment were found similar to that of Kenacort-A orabase cream in this study. Since our study is a preliminary one, additional studies with larger number of subjects, investigating the antibacterial and immunologic effect of this unique medicinal product will help to understand the treatment mechanism of ABS and evaluate clinical benefits and any possible adverse effects of the application of ABS spray.


  • Open Access

    Is the MDR1 C3435T Polymorphism Responsible for Oral Mucositis in Children with Acute Lymphoblastic Leukemia?

    by Kivanc Bektas-Kayhan, Ozlem Kucukhuseyin, Gizem Karagoz, Meral Unur, Oguz Ozturk, Aysegul Unuvar, Omer Devecioglu, Hulya Yilmaz-Aydogan

    Although the functional consequences of MDR-1 polymorphisms have been the subject of numerous studies, to the best to our knowledge, associations with clinical side effects of anticancer drugs have yet to be assessed. Our aim was to clarify any role of the C3435T polymorphism of the MDR1 gene in oral mucositis and its relation with elevated reactive oxygen species (ROS) levels, in children with acute lymphoblastic leukemia (ALL). The distribution of the MDR-1 C3435T polymorphism in 47 patients with ALL was determined by RFLP and compared with that of 68 healthy controls. There were no association in distribution of genotypes of MDR-1 C3435T polymorphism and the risk of ALL. Oral mucositis were detected in 78.7% (n=37) of the patients and significantly related to the MDR-1 CT genotype (p=0.042), as confirmed by logistic regression analysis. Our preliminary data suggest that children carrying the CT genotype are more prone to develop oral mucositis, which might mean that the heterozygous genotype leads to accumulation of more reactive oxygen species. Since a limited number of patients was investigated, further studies are needed to confirm these findings.